AstraZeneca today announced that the U.S. FDA has approved Farxiga (dapagliflozin) to reduce the risk of hospitalization for heart failure in adults …

Medically reviewed by Victor Nguyen, PharmD, MS on July 10, 2019 — Written by Helen Marshall, BPharm, MRPharmS. Republished with permission …

AstraZeneca reported positive phase 3 trial results of Brilinta (ticagrelor) plus aspirin, which reduced the relative risk of cardiovascular events …

Astra Zeneca announced promising results of a phase 3 trial of Farxiga, which showed to reduce the progression of kidney disease or renal death in …

Insulin maker, Novo Nordisk announced this week the results of a clinical trial which demonstrated the superiority of Victoza® (liraglutide) …

A new study from Penn Medicine shows that a person’s individual genetic variation may affect which medications are best to take. Drugs called …

More than 7 million Americans are insulin dependent. And recent findings show that 1-in-4 Americans are rationing their insulin, a dangerous way …

For those with type 2 diabetes, changing course to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of …

A new discovery that may help millions of patients with type 2 diabetes tolerate their medications better was reported this week by researchers at …

Many people with type 2 diabetes will eventually require insulin to keep their diabetes in control. In fact, most experts believe we wait too long in …